Kerry J. Ressler, MD, PhD, has been elected as the next president-elect of the American College of Neuropsychopharmacology (ACNP), and Bill Carlezon, PhD, has been elected as an ACNP council member. Ressler and Carlezon will commence their new ACNP roles in 2022.
Founded in 1961, the ACNP is an international organization of leading brain scientists. Its membership is drawn from scientists in diverse subfields of neuroscience.
Research and education are the primary focuses of the college.
For research, its goals are to offer investigators the opportunity for cross-disciplinary communication and promote the application of various neuroscientific disciplines to the study of all forms of mental illness and their treatment. For education, it aims to encourage young scientists to enter research careers in neuropsychopharmacology and develop and provide information about psychiatric disorders and treatment.
The ACNP also actively promotes and recognizes principles of fairness, equity, and social justice.
Ressler said that he was “honored and humbled” to be nominated and selected as the incoming ACNP president. He also expressed his excitement about having a unique opportunity to contribute toward advancing brain disorder treatment.